Alterity Therapeutics Limited American Depositary Shares (ATHE) Stock Price

ATHEStock

$2.62−45.61%52W

Market Cap$47.71M

P/E—

PEG Ratio—

Div yield—

Beta1.23

ATHE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-47.91%

Price vs S&P 500 (4W)-26.58%

VGM Score52.36

Book Value / Share (Quarterly)$0.14

P/TBV (Annual)2.72x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)370.90%

Cash Flow / Share (Quarterly)$-0.07

Price vs S&P 500 (YTD)-33.46%

Net Profit Margin (TTM)-1363.17%

EPS (TTM)$-0.08

10-Day Avg Trading Volume0.63M

EPS Excl Extra (TTM)$-0.08

Revenue Growth (5Y)142.01%

EPS (Annual)$-0.08

ROI (Annual)-54.52%

Net Profit Margin (5Y Avg)-121814.65%

Cash / Share (Quarterly)$0.12

Revenue Growth QoQ (YoY)140.88%

ROA (Last FY)-50.85%

Revenue Growth TTM (YoY)284.65%

EBITD / Share (TTM)$-0.08

ROE (5Y Avg)-61.70%

Operating Margin (TTM)-1361.81%

Cash Flow / Share (Annual)$-0.07

P/B Ratio1.66x

P/B Ratio (Quarterly)2.91x

Net Income / Employee (Annual)$-1,810,893

EV / Revenue (TTM)19.75x

Net Interest Coverage (TTM)-179.00x

ROA (TTM)-45.47%

EPS Incl Extra (Annual)$-0.08

Current Ratio (Annual)14.52x

Quick Ratio (Quarterly)14.52x

3-Month Avg Trading Volume0.30M

52-Week Price Return-45.61%

Revenue / Employee (TTM)$132,817

Tangible BV / Share (Quarterly)$0.11

P/S Ratio (Annual)41.38x

Asset Turnover (Annual)0.04x

52-Week High$0.55

Operating Margin (5Y Avg)-147767.29%

EPS Excl Extra (Annual)$-0.08

Tangible BV CAGR (5Y)5.72%

26-Week Price Return-38.00%

Quick Ratio (Annual)14.28x

13-Week Price Return-43.64%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)14.52x

Enterprise Value$23.62M

Asset Turnover (TTM)0.03x

Book Value / Share Growth (5Y)-10.64%

Revenue / Employee (Annual)$132,817

Pretax Margin (Annual)-1356.56%

Cash / Share (Annual)$0.12

3-Month Return Std Dev56.30%

Net Income / Employee (TTM)$-1,810,893

ROE (Last FY)-54.77%

Net Interest Coverage (Annual)-509.65x

EPS Basic Excl Extra (Annual)$-0.08

Receivables Turnover (TTM)28.41x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.08

Receivables Turnover (Annual)28.41x

ROI (TTM)-48.11%

P/S Ratio (TTM)41.38x

Pretax Margin (5Y Avg)-121119.68%

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$0.05

Price vs S&P 500 (52W)-61.15%

Year-to-Date Return-22.50%

5-Day Price Return-11.43%

EPS Normalized (Annual)$-0.08

ROA (5Y Avg)-50.67%

Net Profit Margin (Annual)-1363.17%

Month-to-Date Return-22.98%

Cash Flow / Share (TTM)$-0.00

EBITD / Share (Annual)$-0.08

Operating Margin (Annual)-1361.81%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-61.26%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.08

P/TBV (Quarterly)1.00x

P/B Ratio (Annual)2.91x

Pretax Margin (TTM)-1356.56%

Book Value / Share (Annual)$0.14

Price vs S&P 500 (13W)-46.32%

Beta1.23x

Revenue / Share (TTM)$0.01

ROE (TTM)-48.25%

52-Week Low$0.01

vGradeD

gGradeA

mGradeD

vgmGradeC

ATHE Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.00

Industry Peers — Pharmaceuticals(574)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
ATHEAlterity Therapeutics Limited American Depositary Shares	D	A	D	41.4x	284.6%	—	—	$2.62
LLYEli Lilly & Co.	D	B	A	14.9x	49.6%	83.4%	27.6%	$1257.03
JNJJohnson & Johnson	D	C	B	6.2x	7.8%	67.7%	14.9%	$255.56
ABBVABBVIE INC.	D	C	A	7.8x	10.4%	72.8%	-2.9%	$285.42
MRKMerck & Co., Inc.	D	C	A	5.4x	4.6%	77.3%	21.2%	$145.95
NVSNovartis AG	C	C	B	4.9x	3.3%	75.0%	15.3%	$150.62
AZNAstraZeneca PLC	C	B	B	4.3x	8.6%	81.3%	21.9%	$165.41
ABTAbbott Laboratories	C	C	B	3.9x	8.1%	56.8%	8.2%	$104.89
NVONovo-Nordisk A/S	B	C	C	3.5x	5.6%	80.7%	20.7%	$38.83
PFEPfizer Inc.	C	D	A	2.6x	-0.2%	74.7%	-3.5%	$29.58
VRTXVertex Pharmaceuticals Inc	D	C	B	10.1x	10.2%	86.0%	8.3%	$499.74
BMYBristol-Myers Squibb Co.	B	B	B	2.5x	3.1%	71.7%	—	$59.75
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	C	C	B	2.3x	5.0%	73.6%	-0.5%	$49.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	D	B	1.8x	13.4%	72.8%	-8.2%	$40.61
REGNRegeneron Pharmaceuticals Inc	C	C	A	5.2x	9.3%	86.0%	6.3%	$790.74
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	A	2.1x	3.1%	65.5%	-12.6%	$19.67
TEVATeva Pharmaceutical Industries Limited	D	C	A	2.8x	4.1%	52.9%	—	$41.50
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.3x	31.1%	88.5%	—	$369.06
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	A	13.8x	10.0%	—	-12.1%	$60.96
ZTSZOETIS INC.	C	C	B	3.5x	1.4%	71.6%	12.0%	$79.38
ALNYAlnylam Pharmaceuticals, Inc.	D	A	C	6.5x	95.1%	79.7%	—	$231.83
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3215.5x	-67.6%	81.2%	—	$33.53
UTHRUnited Therapeutics Corp	C	C	B	7.2x	2.5%	86.1%	19.3%	$533.12
GMABGenmab A/S ADS	D	C	A	5.5x	22.3%	93.0%	6.8%	$37.00
VTRSViatris Inc. Common Stock	B	C	A	1.5x	4.4%	40.3%	—	$18.66
INSMInsmed, Inc.	F	A	C	18.5x	185.8%	83.5%	—	$96.27
ASNDAscendis Pharma A/S Ordinary Share	D	A	B	11.9x	113.3%	91.3%	—	$225.25
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.0x	12.6%	88.4%	-1.4%	$210.23
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	18.2x	202.4%	94.4%	—	$66.39
CORTCorcept Therapeutics Inc.	F	C	A	14.3x	16.0%	98.3%	-0.5%	$110.16
ELANElanco Animal Health Incorporated Common Stock	D	B	B	2.3x	11.9%	55.4%	29.9%	$23.55
SMMTSummit Therapeutics Inc. Common Stock	F	—	C	12187.5x	—	—	—	$14.63
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	C	B	3.1x	-0.9%	61.4%	16.5%	$13.07
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.1x	11.2%	79.6%	-17.0%	$54.68
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	8.1x	149.0%	91.5%	—	$449.74
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	213.8x	2928.4%	—	—	$84.95
CYTKCytokinetics Inc.	F	D	B	127.3x	-21.1%	—	—	$61.95
PTGXProtagonist Therapeutics, Inc	F	B	B	29.5x	34.8%	—	—	$128.75
TGTXTG Therapeutics, Inc.	D	B	B	10.3x	76.1%	82.4%	—	$53.97
AXSMAxsome Therapeutics, Inc	D	B	C	10.6x	56.9%	93.2%	—	$157.14
ARWRArrowhead Research Corporation	D	A	C	11.8x	16.9%	—	—	$55.90
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$88.13
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	5995.2x	—	—	—	$79.90
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	8.2x	-7.5%	98.2%	—	$42.94
ALKSAlkermes Inc. plc	D	C	B	4.1x	10.8%	84.6%	—	$41.22
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	789.2x	—	—	—	$241.76
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	D	C	A	2.0x	9.3%	39.3%	-18.4%	$19.18
KNSAKiniksa Pharmaceuticals International, plc Class A Ordinary Shares	D	B	A	7.3x	58.9%	89.8%	—	$78.59
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	24.7x	53.5%	70.9%	—	$86.17
LGNDLigand Pharmaceuticals Inc.	D	B	B	20.3x	54.9%	95.4%	—	$295.54
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	—	—	—	—	$142.78

About Alterity Therapeutics Limited American Depositary Shares

Alterity Therapeutics is a clinical-stage biotechnology company developing novel treatments for Parkinson's disease and other neurodegenerative disorders. The company's proprietary pipeline targets the underlying pathology of these diseases through compounds designed to bind excess iron, reduce alpha-synuclein aggregation, and restore neuronal function. Lead programs include ATH434 and related candidates, supported by a broader drug discovery platform.